UniProt B2KJ46
Carbonyl Reductase (B2KJ46)
Carbonyl Reductase (UniProt B2KJ46), EC 1.1.1.-: 10 experimental structures on GenesisL1, 4 ligands bound, 31 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- B2KJ46
- Protein
- Carbonyl Reductase
- EC
- 1.1.1.-
- Experimental structures
- 10
- Predicted models
- 0
- Ligands
- 4
- Pockets
- 31 · 5 records with a druggable one
Structures
10 records of B2KJ46 in the MolNFT archive: 10 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 3CTM | Crystal Structure of a Carbonyl Reductase from Candida Parapsilosis with anti-Prelog… | x-ray diffraction | A, B, D, C, E, F, G, H | — | — |
| 3CTM | Crystal structure of a carbonyl reductase from candida parapsilosis with anti-prelog… | x-ray diffraction | A, B, D, C, E, F, G, H | — | — |
| 7DLD | Crystal structures of (S)-carbonyl reductases from Candida parapsilosis in different… | x-ray diffraction | A, B | MG | 6 (best 0.70) |
| 7DLD | Crystal structures of (S)-carbonyl reductases from candida parapsilosis in different… | x-ray diffraction | A, B | MG | — |
| 7DLM | Short chain dehydrogenase (SCR) crystal structure with NADPH | x-ray diffraction | A, B | NDP | 5 (best 0.74) |
| 7DLM | Short chain dehydrogenase (scr) crystal structure with NADPH | x-ray diffraction | A, B | NDP | 5 (best 0.74) |
| 7DN1 | Hetero-oligomers of SCR-SCR2 crystal structure with NADPH | x-ray diffraction | A | NDP | 5 (best 0.73) |
| 7DN1 | Hetero-oligomers of scr-SCR2 crystal structure with NADPH | x-ray diffraction | A | NDP | — |
| 7VYQ | Short chain dehydrogenase (SCR) cryoEM structure with NADP and ethyl 4-chloroacetoacetate | electron microscopy | A, B, F, G | NAP, 83I | 10 (best 0.84) |
| 7VYQ | Short chain dehydrogenase (scr) cryoem structure with NADP and ethyl 4-chloroacetoacetate | electron microscopy | A, B, F, G | NAP, 83I | — |
Ligands
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.